semaglutide type 1 diabetes trial A clinical is currently recruiting in Sydney! The trial, called REducing Cardiometabolic Risk with in Type 1 diabetes (The RESET1 study), will investigate whether the use of Subcutaneous weekly semaglutide with automated
Pay in 4 interest-free payments of $7.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4






















